Stay updated on Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Sign up to get notified when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.

Latest updates to the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page
- CheckyesterdayChange DetectedA new revision entry v3.5.4 is added to the history, and the previous revision v3.5.3 is removed from the current view.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe Record History now shows Revision: v3.5.3, replacing the previous v3.5.2. This indicates a minor platform update to ClinicalTrials.gov and does not modify the study data or results on the page.SummaryDifference0.1%

- Check30 days agoChange DetectedUpdated the page’s revision identifier from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history now includes revision v3.5.0 and excludes revision v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedA new page revision (v3.4.3) was added and the previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check94 days agoChange Detected- The revision history now shows Revision: v3.4.2 in place of Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Enter your email address, and we'll notify you when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.